Sexual health is a critical component of overall well-being and quality of life. Peptide therapies and hormone optimization offer targeted approaches that address the root causes of sexual dysfunction rather than merely treating symptoms.
How These Compounds Help
PT-141 (bremelanotide) is a melanocortin receptor agonist that works centrally in the brain to enhance sexual desire and arousal. Unlike PDE5 inhibitors that only address erectile mechanics, PT-141 targets the neurological pathways governing libido. It is FDA-approved for female hypoactive sexual desire disorder and shows significant benefits for male sexual dysfunction as well.
Enclomiphene supports sexual health by stimulating natural testosterone production through selective estrogen receptor modulation. By increasing LH and FSH, it raises endogenous testosterone levels — improving libido, sexual function, and vitality while preserving testicular function and fertility.
Testosterone optimization through TRT directly addresses hypogonadal sexual dysfunction, restoring the hormonal foundation necessary for healthy libido, erectile function, and sexual performance.
Who This Is For
This goal category is relevant for individuals experiencing:
- Decreased libido or sexual desire
- Erectile dysfunction or arousal difficulties
- Hormonal imbalances affecting sexual function
- Low testosterone-related sexual health decline
- Desire to improve sexual health while preserving fertility
A Comprehensive Approach
Sexual health optimization often requires addressing multiple factors:
- Hormonal foundation: Ensure testosterone, estrogen, and DHEA are optimized
- Neurological drive: PT-141 for central arousal enhancement
- Vascular health: Cardiovascular fitness and nitric oxide support
- Psychological factors: Stress management and sleep optimization
- Monitoring: Track total/free testosterone, estradiol, SHBG, prolactin, and thyroid markers